glp-1 iih glp 1 for Efficacy and Safety of GLP‐1 and Dual GIP/GLP‐1 Receptor Agonists in Idiopathic Intracranial Hypertension: A Systematic Review and Meta‐Analysis - Stefanou - 2025 iih glp 1 NeuroOp Guru:

The SURPASS program (for type 2 diabetes) and SURMOUNT program (for obesity) together enrolled over 20,000 participants across multiple Phase III trials

Moreover, Li et al

Gastrointestinal side effects such as nausea, vomiting, and diarrhoeawhich are common with GLP-1 medicationscan contribute to dehydration, electrolyte imbalances, and general malaise

NABH-accredited centre with advanced infrastructure Sterile, hygienic environment with daily fumigation protocols Doctor-led plans using high-quality pharmaceutical glutathione Personalised dose adjustments and recovery tracking Trained post-procedure care team and a comfortable, patient-friendly setting Found the best clinic